Visceral Therapeutics

Manufacturing · Canada · 11-50 Employees

View Company Info for Free

Overview

Headquarters

Canada

Revenue

<$5 Million

Industry

Manufacturing Pharmaceuticals Business Services Research & Development
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1

About Visceral Therapeutics

Visceral Therapeutics is an emerging Canadian biotechnology company focused on addressing unmet medical needs in the gastrointestinal space through innovative cannabinoid-based therapeutics. The company aims to bridge the gap between conventional pharmaceuticals and cannabinoid science by enhancing the efficacy of safe therapeutics with the synergistic effects of CB-1 and CB-2 receptor activity. With a diverse pipeline of products, Visceral Therapeutics targets patients with little or no options for treatment. Their commitment to advanced research positions them as a leader in the bio-pharmaceutical industry.Explore more
Popular SearchesVisceral TherapeuticsSIC Code 28,283NAICS Code 32,325Show more

Is Visceral Therapeutics your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to Visceral Therapeutics

Compare insights from companies similar to Visceral Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Visceral Therapeutics

<$5M
11-50
Private
-
-
N/A
<$5M
11-50
Private
-
2003
SC
Sam ChenDirector, Formulation Development
<$5M
1-10
Private
<$5M
2019
Bradley Miles, Chief Executive Officer & Co-Founder at Pike Therapeutics
Bradley MilesCEO & Co-Founder
<$5M
1-10
Private
-
2013
Elaine Allison, Co-Founder & Chief Executive Officer at Novelogics Biotechnology
Elaine AllisonCo-Founder & CEO
<$5M
11-50
Private
-
2015
N/A
<$5M
11-50
Private
-
2020
KL
Kevin LeshukPresident & CEO
<$5M
1-10
Private
-
2006
N/A
Illustration of an envelope

Company Profile Activity

i

Among all Manufacturing companies

Low Activity

High Activity

Activity Insights

Visceral Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.

What does this means?

Visceral Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Visceral Therapeutics.

Visceral Therapeutics Tech Stack

A closer look at the technologies used by Visceral Therapeutics

See more technologies

Top Manufacturing Companies

Frequently Asked Questions Regarding Visceral Therapeutics

What is Visceral Therapeutics's official website?
Visceral Therapeutics's official website is www.visceraltherapeutics.com
What is Visceral Therapeutics's Revenue?
Visceral Therapeutics's revenue is <$5 Million
What is Visceral Therapeutics's SIC code?
Visceral Therapeutics's SIC: 28,283
What is Visceral Therapeutics's NAICS code?
Visceral Therapeutics's NAICS: 32,325
How many employees does Visceral Therapeutics have?
Visceral Therapeutics has 11-50 employees
What industry does Visceral Therapeutics belong to?
Visceral Therapeutics is in the industry of: Manufacturing, Pharmaceuticals, Business Services
What is Visceral Therapeutics competition?
Visceral Therapeutics top competitors include: FORUS Therapeutics, Pike Therapeutics, Glysantis, Novelogics Biotechnology
What technology does Visceral Therapeutics use?
Some of the popular technologies that Visceral Therapeutics uses are: SoftLayer
What does Visceral Therapeutics do?

Visceral Therapeutics is an emerging Canadian biotechnology company focused on addressing unmet medical needs in the gastrointestinal space through innovative cannabinoid-based therapeutics. The company aims to bridge the gap between conventional pharmaceuticals and cannabinoid science by enhancing the efficacy of safe therapeutics with the synergi... stic effects of CB-1 and CB-2 receptor activity. With a diverse pipeline of products, Visceral Therapeutics targets patients with little or no options for treatment. Their commitment to advanced research positions them as a leader in the bio-pharmaceutical industry.Read More

Is Visceral Therapeutics a public company?
Visceral Therapeutics is private company therefore does not currently have an official ticker symbol
See more information about Visceral Therapeutics

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.